About: http://webisa.webdatacommons.org/1977471

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Summarizing, the RAS field is rapidly moving beyond angiotensin II, and many new drugs start to emerge, including drugs that act on one specific signaling pathway of angiotensin II (biased AT1 receptor agonists").
http://www.w3.org/ns/prov#wasQuotedFrom	grc.org